Littlefield, Bruce A.,Funahashi, Yasuhiro,Uenaka, Toshimitsu
申请号：
AU2015225436
公开号：
AU2015225436A1
申请日:
2015.03.02
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
Methods for treating cancer (e.g., breast cancer, lung cancer, pancreatic cancer, primitive neuroectodermal tumors, lung cancer, ovaria cancer, endometrial cancer, pharyngeal cancer, esophageal cancer, and sarcoma) in a subject (such as an human patient) in need thereof by administering eribulin (e.g., eribulin mesylate, i.e., E7389, Halaven) in combination with one or more mammalian target of rapamycin (mTOR) inhibitors (e.g., everolimus, ridaforolimus, and temsirolimus), and kits therefor are provided.
